leisure time -WSS

leisure time

author：knowledge 2025-10-02 20:47:47 - browse：639

Photography of the US department of health and human services in Silver Spring MD — Manuel Balce Ceneta/AP

An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

Triple-check your data or we’ll reject your device, the FDA warned.

The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Cigna to pay $172 million to settle Medicare Advantage fraud probe

WSS

Retired US general questions alleged Putin, Prigozhin meeting

Retired US general questions alleged Putin, Prigozhin meeting

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Leqembi, other new Alzheimer’s drugs require better biomarkers

Intercept Pharmaceuticals sells itself for less than $1 billion

Would Medicare drug price negotiations stall in a shutdown?

entertainment

leisure time

leisure time

Cancer drug shortages should be causing more outrage

How one patient went off dialysis — and others can too

Virginia high school admissions case could be legal follow

How the political right came to back psychedelics to treat trauma

Jerome Adams on the need for new antivirals for Covid

Menendez indictment could see pharma lose a key ally

New air purifier tech could be key to improving indoor air quality

Why ADHD is under

Jerome Adams on the need for new antivirals for Covid

Elizabeth Holmes on track for early release from her 11

focus

Menendez indictment could see pharma lose a key ally

HCA discloses massive data breach affecting 11 million patients

Leqembi, other new Alzheimer’s drugs require better biomarkers

Charles Manson follower Leslie Van Houten released from prison after 53 years

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

Cigna to pay $172 million to settle Medicare Advantage fraud probe

entertainment

explore

hotspot

hotspot